Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12476
CALL
BrightSpring Health Services
BTSG
$12.2B
| $21.6K | ﹤0.01% |
1,900
-700
| -27% | -$7.64K |
|
|
OGG
12477
CALL
Osisko Gold Group
OGG
$872M
| $21.6K | ﹤0.01% |
11,600
-700
| -6% | -$1.48K |
|
|
IRD
12478
Opus Genetics
IRD
$300M
| $21.6K | ﹤0.01% |
14,098
-65,432
| -82% | -$113K |
|
12479
CALL
Envela
ELA
$416M
| $21.6K | ﹤0.01% |
+4,800
| New | +$21.9K |
|
12480
CALL
Lifecore Biomedical
LFCR
$179M
| $21.5K | ﹤0.01% |
4,200
-25,600
| -86% | -$152K |
|
12481
PUT
Kearny Financial
KRNY
$605M
| $21.5K | ﹤0.01% |
3,500
+3,200
| +1,067% | +$18.3K |
|
12482
CALL
SES AI
SES
$223M
| $21.5K | ﹤0.01% |
17,200
+16,400
| +2,050% | +$22.3K |
|
12483
F&G Annuities & Life
FG
$3.59B
| $21.5K | ﹤0.01% |
565
-15,783
| -97% | -$618K |
|
|
ORKA
12484
PUT
Oruka Therapeutics
ORKA
$7.35B
| $21.4K | ﹤0.01% |
+467
| New | +$18.6K |
|
|
CVIIW
12485
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
| $21.4K | ﹤0.01% |
61,232
-42,949
| -41% | -$11.3K |
|
12486
PUT
Karyopharm Therapeutics
KPTI
$45.8M
| $21.4K | ﹤0.01% |
1,647
+240
| +17% | +$3.97K |
|
|
NOTV
12487
PUT
DELISTED
Inotiv
NOTV
| $21.4K | ﹤0.01% |
12,900
-13,500
| -51% | -$49.7K |
|
12488
PUT
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16.1B
| $21.4K | ﹤0.01% |
200
+100
| +100% | +$10.3K |
|
|
GRTS
12489
CALL
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $21.4K | ﹤0.01% |
34,600
-138,700
| -80% | -$117K |
|
|
12490
SES AI
SES
$223M
| $21.3K | ﹤0.01% |
17,041
+6,964
| +69% | +$9.45K |
|
|
WSR
12491
PUT
DELISTED
Whitestone REIT
WSR
| $21.3K | ﹤0.01% |
1,600
+900
| +129% | +$11.1K |
|
12492
CALL
Citi Trends
CTRN
$616M
| $21.3K | ﹤0.01% |
1,000
-2,500
| -71% | -$57.4K |
|
12493
PUT
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $21.3K | ﹤0.01% |
+400
| New | +$21.3K |
|
12494
PUT
SelectQuote
SLQT
$129M
| $21.3K | ﹤0.01% |
7,700
+6,700
| +670% | +$16.1K |
|
12495
CALL
TransAlta
TAC
$4.05B
| $21.2K | ﹤0.01% |
3,000
-37,500
| -93% | -$257K |
|
12496
PUT
INmune Bio
INMB
$60.2M
| $21.2K | ﹤0.01% |
2,400
-1,100
| -31% | -$10.8K |
|
12497
CALL
Milestone Pharmaceuticals
MIST
$137M
| $21.1K | ﹤0.01% |
15,900
+12,600
| +382% | +$20.3K |
|
12498
PUT
Pangaea Logistics
PANL
$487M
| $21.1K | ﹤0.01% |
2,700
-4,100
| -60% | -$30.5K |
|
|
ORGN
12499
DELISTED
Origin Materials
ORGN
| $21.1K | ﹤0.01% |
782
-418
| -35% | -$11.2K |
|
12500
Black Diamond Therapeutics
BDTX
$116M
| $21.1K | ﹤0.01% |
4,529
-6,557
| -59% | -$35.2K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.